Join us at the Cannabis Europa Virtual event Prohibition Partners LIVE on 22 & 23 June 2020
Cannabis Denmark stage: the complete medical cannabis ecosystem in Europe
Denmark is on track to build one of the world’s largest cultivation footprint in medical cannabis, all based on full GMP certified, pharma-grade production. Launching in 2018, the Danish medical cannabis ecosystem has evolved significantly. This rapid progress has been driven by a combination of high regulatory standards, reliable access to sustainable energy, deep expertise in the global pharma industry, and strong roots in building world-class horticulture businesses.
But the most significant development is yet to come, and will be based on Denmark’s commitment to research and development, industrialization and automation, and established strengths in product design, innovative pharma sector, and collaboration. We see examples of successful development across the value chain, with cultivation at a European scale, processing and extraction based on high standards, and innovative startups emerging from Danish universities. The Denmark stage will present examples of each.
Invest in Denmark is partnering with Prohibition Partners LIVE to help advance the international cannabis industry and help to unlock the potential of medical cannabis. Sharing a mutual goal of high standards, international leadership and industry-leading education the partnership will present world-class research and European-leading speakers to a global audience via the CANNABIS DENMARK virtual stage at Prohibition Partners LIVE on June 23 2020.
Join us to hear from leading Danish firms and organisations.
Speakers
-
Morten Snede, CEO of Spectrum Therapeutics
Morten Snede – CEO - Spectrum Therapeutics – Canopy Growth’s largest asset in Europe and among the first to obtain a licence to produce and export medical cannabis. Developing a vertically integrated medical cannabis business in Denmark, building on its industry leading cultivation facility and offering a full offering of products for the Danish and European market.
Visit their website -
Peter Emil Sigetty, CEO of Aureum A/S
Offers a complete outsourcing solution for the manufacturing of medicinal cannabis extracts, and backed by GreenField Global Opportunities Fund and Vitalis Extraction Technologies. Services cover all aspects of contract manufacturing, from product formulations and pilot production, to procurement of raw material and packaging.
Visit their website -
Anne Ladegaard Skov, Professor at DTU/ Founder of Silease
Developing novel transdermal drug-delivery technology providing precise and constant dosing over extended time period with the possibility to adjust release of cannabinoids. Technology originates from multi-year project at Danish Polymer Centre of Technical University of Denmark. -
Nick Milne, Founder and Chief Science Officer of Octarine Bio
Harnesses synthetic biology to engineer novel cannabinoid and psilocybin derived molecules with improved pharmacokinetic and therapeutic properties. Proprietary enzyme platform technologies - backed by Bruce Linton and Oskare Capital - to efficiently modify molecules, and fermentation platforms to effectively scale-up production.
Visit their website
Information
When?
Tuesday 23 June 2020 at 15:30-17:30 UK time / 16:30-18:30 DK timeWhere?
OnlineSignup?
Click to sign up at Prohibition Partners websiteContact Get in touch
Want to know more about the medical cannabis industry and opportunities in Denmark? Fill out the form and we will get back to within 48 hours.
want to contact us now about medical cannabis in Denmark?
Please contact our dedicated advisors: